Pepgen to present at the 24th annual needham virtual healthcare conference

Boston--(business wire)--pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that james mcarthur, phd, president and ceo of pepgen, will present at the 24th annual needham virtual healthcare conference on wednesday, april 9, 2025 at 1:30pm et. a webcast of the corporate presentation will be available on the "even.
PEPG Ratings Summary
PEPG Quant Ranking